Process
My Multibagger Screening Checklist for NSE/BSE Stocks
This is the checklist I like to run a stock through before I get emotionally attached to the story. It doesn’t guarantee a multibagger, but it filters out a lot of obvious junk so I can spend time where the odds are a bit less terrible.
1. Basic sanity: business and liquidity
- Do I understand what the company actually does? If I can’t explain it to a friend in 2–3 sentences, I’m probably not ready to invest.
- Is there enough trading volume? For very small caps, I don’t want to be stuck with a position I can’t exit.
- Is it a “theme of the month”? If the stock only appears in hype lists and not in serious research, that’s a red flag.
2. Growth: top line and bottom line
I look for companies where both sales and profits are moving in the right direction over multiple years, not just one lucky year.
- Revenue growth: healthy, ideally double‑digit, over the last 3–5 years.
- Profit growth: earnings per share (EPS) trending up, not flat or shrinking while revenue grows.
- Margins: gross and operating margins stable or improving, not collapsing because of pricing pressure.
3. Quality: returns and balance sheet
- ROE / ROCE: decent return on equity and capital employed compared to peers. Chronically low returns make it harder to be a big winner.
- Debt: debt‑to‑equity under control. Some industries can handle more, but huge leverage plus cyclicality is a dangerous mix.
- Cash flows: profits backed by cash flow over a cycle, not just accounting tricks.
4. Moat and industry tailwinds
Numbers are a snapshot, but I also want a sense of why this business could keep winning.
- Moat: does the company have cost advantages, strong brand, distribution, IP, switching costs, or network effects?
- Industry growth: is the sector itself growing or shrinking? It’s easier to find a 10x in a rising industry.
- Competitive landscape: is it a commodity business with 50 similar players, or a niche where a few companies dominate?
5. Management and governance
- Promoter history: any serious governance issues, pledging, or regulatory run‑ins?
- Skin in the game: do promoters hold a meaningful stake, and is that stake gradually increasing or decreasing?
- Capital allocation: has management used past cash flows wisely (debt reduction, sensible capex, buybacks/dividends) or chased random ventures?
6. Valuation: great business vs great price
I don’t need the absolute lowest P/E in the sector, but I don’t want to pay any price just because someone on social media called it a multibagger.
- Compare to history: how does today’s valuation (P/E, EV/EBITDA, P/S) look versus its own 5‑year range?
- Compare to peers: is the premium (or discount) to peers justified by growth and quality?
- Scenario thinking: what needs to go right for this valuation to make sense 3–5 years out?
7. Position sizing and risk
A great business bought in the wrong size can still blow up your portfolio. I try to think about risk before the buy button, not when the stock is already down 40%.
- Max position size for aggressive ideas so a single position can’t wreck the portfolio.
- Portfolio view: avoid having too many names all exposed to the same macro risk (e.g., only export‑oriented small caps).
- Exit logic: what would make me admit I was wrong — thesis break, numbers crack, or governance red flags?
8. Process over prediction
No checklist can promise a 10x. But a consistent process can help you:
- Avoid the most obvious landmines.
- Spend time on businesses that at least have a chance to compound.
- Stay rational when markets are euphoric or panicked.
Want to see this checklist in action?
In the MultibaggerLab newsletter, I regularly walk through ideas using this exact framework across:
- Indian stocks (Nifty, mid and small caps).
- US markets (Nasdaq, S&P 500 leaders).
- Bitcoin and broader macro context.
It’s free to join and focused on deep, educational breakdowns — no spam, no pump‑and‑dump. Subscribe via the homepage →
Disclaimer: This is not investment advice or a stock recommendation. Always do your own research and consider your risk profile.